Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2011-06-28
2011-06-28
Long, Scott (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
Reexamination Certificate
active
07968088
ABSTRACT:
Intravenous administration of bone marrow cells collected from rat bone marrow or peripheral blood to a rat cerebral infarction model was found to be effective in treating cerebral infarction. Human and murine bone marrow stem cells showed similar effects. Mesenchymal cells such as bone marrow cells, cord blood cells, or peripheral blood cells can be used as agents for in vivo administration against cranial nerve diseases.
REFERENCES:
patent: 6673606 (2004-01-01), Tennekoon et al.
patent: 2002/0123465 (2002-09-01), Twardzik et al.
patent: 2002/0132343 (2002-09-01), Lum
patent: 2002/0168766 (2002-11-01), Gold et al.
patent: 2003/0161818 (2003-08-01), Weiss et al.
patent: 2002-027983 (2002-01-01), None
patent: 2002-544234 (2002-12-01), None
patent: 2004-544234 (2002-12-01), None
patent: WO 99/01145 (1999-01-01), None
patent: WO 01/05944 (2001-01-01), None
patent: WO 01/66698 (2001-09-01), None
patent: WO 02/00849 (2002-01-01), None
patent: WO 03/025167 (2003-03-01), None
patent: WO 03/038075 (2003-05-01), None
Chen et al (Stroke. 2001; 32:1005-1011).
Tocci et al. (Hematol-J. Feb. 2003. 4(2): 92-96).
Reyes et al. (Blood. Nov. 1, 2001; 98(9): 2615-2625).
Fernandez et al. Bone Marrow Transplantation. 1997; 20: 265-271).
Ukai et al., “Mesenchymal Stem Cells Derived from Peripheral Blood Protects against Ischemia,” Journal of Neurotrauma, 2007, 24(3):508-520.
Kennea et al., “Perinatal applications of neural stem cells,” Best Practice & Research Clinical Obstetrics and Gynaecology, 2004, 18(6), 977-994.
Tocci et al., “Mesenchymal stem cell: use and perspectives,” The Hematology Journal, 2003, 4, 92-96.
The Hokkaido Shimbun, “Treatment of cerebral infarction with the patient's own bone-marrow stem cells collected in advance,” Sapporo Medical University, Jul. 7, 2003, one page (and English Translation, two pages).
“Gene therapy for rat glioma based on mesenchymal stem cell transplantation,” Cancer Science, Sep. 25-27, 2003, Proceedings of the 62ndAnnual Meeting of the Japanese Cancer Association, five pages including cover, table of contents, p. 325 and last page of publication (and English translation of p. 325, one page).
Database Biosis on STN, (Last Updated on Stn: Jun. 19, 2003) abstract No. 200300283245 & S. Ilhoshi et al., “Intravenous administration of autologous bone marrow cells repairs the ischemic lesions in the rat middle cerebral artery occlusion model”, Society for Neuroscience Abstract Viewer & Itinerary Planner, (2002), vol. 2002, abstract No. 237.8., http://sfn.scholarone.com.
D. Lu et al., “Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migratein to brain and improve neurological outcome”, Neuroreport, 2001, vol. 12, No. 3, pp. 559-563.
J. Chen et al., “Therapeutic benefit of intravenous administ ratino of bone marrow stromal cells after cerebral ischemia in rats”, Stroke, 2001, vol. 32, No. 4, pp. 1005-1011.
K. Chu et al., “Human neural stem cells can migrate, differentiate and integrate after intravenous transplantation in adult rats with transient forebrain ischemia”, Nurosci. Lett., Jun. 5, 2003, vol. 343, No. 2, pp. 129-133.
Y. Akiyama et al., “Remyelination of the spinal cord following intravenous delivery of bone marrow cells”, Glia., (2002), vol. 39, pp. 229-236.
A. Mahmood et al., “Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells”, Neurosurgery, 2002, vol. 49, No. 5, pp. 1196-1203.
Database Medline on STN, (2002), abstract No. 2002333228 & D. Lu et al., “Intravenous administration of human unbilical cord blood reduces neurological deficit in the rat after traumatic brain injury”, Cell Transplant. (2002), vol. 11, No. 3, pp. 275-281.
Database Biosis on STN, (2001), abstract No. 200100547979 & Y. Akiyama et al., “Remyelination of spinal cord axons by intravenous delivery of bone marrow cells”, Society for Neuroscience Abstracts, 2001, vol. 27. No. 2, p. 1562.
Database Biosis in STN, (2003), abstract No. 200300315449 & P. Lu et al., “Transplantation of bone marrow stromal cells (MSCS) and BDNF-transducer MSCS promotoes robust axonal growth after spinal cord injury”, Society for Neuroscience Abstract Viewer & Itinerary Planner, 2002, vol. 202, abstract No. 634.11 http://sfn.scholarone.com.
Ma Keane-Moore et al., “Human mesenchylmal stem cells can be genetically modified to function as antigen presenting cells”, Blood, (1998), vol. 92, No. 10, suppl. 1, part 1 to 2, p. 338A, Abstract #1388.
Aggarwal, et al., “Human mesenchymal stem cells modulate allogeneic immune cell responses”, Blood, vol. 105, No. 4,. pp. 1815-1822, (2005).
Akiyama, et al., “Transplantation of Clonal Neural Precursor Cells Derived from Adult Human Brain Establishes Functional Peripheral Myelin in the Rat Spinal Cord”, Experimental Neurology, vol. 167, pp. 27-39 (2001).
Archer, et al., “Myelination by Cryopreserved Xenografts and Allografts in the Myelin-Deficient Rat”, Experimental Neurology, vol. 125, pp. 268-277 (1994).
Auner, et al., “Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases”, Ann Hematol, vol. 84, pp. 532-537 (2005).
Bang, et al., “Autologous Mesenchymal Stem Cell Transplantation in Stroke Patients”, Ann Neurol, vol. 57, pp. 874-882 (2005).
Barker, et al., “Acute Stroke: Evaluation with Serial Proton MR Spectroscopic Imaging”, Radiology, vol. 192, pp. 723-732 (1994).
Bederson, et al., “Evaluation of 2, 3, 5-Triphenyltetrazolium Chloride as a Stain for Detection and Quantification of Experimental Cerebral Infarction in Rats”, Stroke, vol. 17, No. 6, pp. 1304-1308 (1986).
Bender, et al., “Identification and Comparison of CD34-Positive Cells and Their Subpopulations From Normal Peripheral Blood and Bone Marrow Using Multicolor Flow Cytometry”, Blood, vol. 77, No. 12, pp. 2591-2596 (1991).
Bernstein, et al., “Suppression of Human Cytotoxic T Lymphocyte Responses by Adherent Peripheral Blood Leukocytes”, Annals New York Academy of Science, vol. 532, pp. 206-213 (1988).
Bjornson, et al., “Turning Brain into Blood: A Hematopoietic Fate Adopted by Adult Neural Stem Cells in Vivo”, Science, vol. 283, pp. 534-537 (1999).
Blakemore, et al., “Extensive Oligodendrocyte Remyelination following Injection of Cultured Central Nervous System Cells into Demyelinating Lesions in Adult Central Nervous System”, Dev. Neurosci., vol. 10, pp. 1-11 (1988).
Wiesel, et al., “Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve”, Nature, vol. 266, p. 68-69, (1977).
Brown, et al., “Factors That Influence the Collection and Enraftment of Allogeneic Peripheral-Blood Stem Cells in Patients With Hematologic Malignancies”, Journal of Clinical Oncology, vol. 15, No. 9, pp. 3067-3074 (1997).
Chalmers-Redman, et al., “In Vitro Propagation And Inducible Differentiation of Multipotential Progenitor Cells From Human Fetal Brain”, Neuroscience, vol. 76, No. 4, pp. 1121-1128 (1997).
Chen, et al., “Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats”, Journal of the Neurological Sciences, vol. 189, pp. 49-57 (2001).
Chopp, et al., “Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation”, NeuronReport, vol. 11, No. 13, pp. 3001-3005 (2000).
Deshari, et al., “Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer”, Cancer Gene Therapy, vol. 10, pp. 75-85 (2003).
Escolar, et al., “Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Diseas
Hamada Hirofumi
Honmou Osamu
Foley & Lardner LLP
Long Scott
Maebius Stephen B.
Talapatra Sunit
LandOfFree
Internally administered therapeutic agents for cranial nerve... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Internally administered therapeutic agents for cranial nerve..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Internally administered therapeutic agents for cranial nerve... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2729679